The weekly litigation news digest is live. Subscribe now

Patent Oppositions in immune drugs industry

Explore the competitive field of immune drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in immune drugs technology and learn how to protect your intellectual property.

Get Patent Opposition Report for immune drugs

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Report

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the immune drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the immune drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Nov 20, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name
Method And Compositions For Cellular ImmunotherapyFRED HUTCHINSON CANCER RESEARCH CENTEROct 8, 2025BOULT WADE TENNANT
Novel Lipids And Compositions For The Delivery Of TherapeuticsARBUTUS BIOPHARMAJul 23, 2025ARROWHOUSE
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSJul 16, 2025TEVA PHARMACEUTICALS
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSJul 15, 2025MAIWALD
Methods For Preventing Or Treating Allergy By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSApr 30, 2025HAMPTON KNOWLES
Methods For Preventing Or Treating Allergy By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSApr 29, 2025LUIGI
Novel Lipids And Compositions For The Delivery Of TherapeuticsARBUTUS BIOPHARMAApr 29, 2025MODERNA
Mixture Of Non-Digestible Oligosaccharides For Stimulating The Immune SystemNUTRICIAApr 10, 2025BRULIE
Mixture Of Non-Digestible Oligosaccharides For Stimulating The Immune SystemNUTRICIAMar 27, 2025ARLA FOODS AMBA
Pharmaceutical Formulations Comprising 4-{(1 R)-2-[(6-{2-[(2,6-Dichlorobenzyl)Oxy]Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2-(Hydroxymethyl)PhenolGLAXO GROUPMar 26, 2025ELKINGTON AND FIFE

To stay ahead in the competitive immune drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the immune drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Nov 20, 2025
Patent NumberPublication DateTitleApplicantTotal Oppositions
Oct 12, 2022S1P Receptor Modulators For Treating Multiple SclerosisNOVARTIS23
Dec 13, 2023Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARE10
Sep 11, 2019Binding Molecules For Bcma And Cd3BOEHRINGER INGELHEIM8
Aug 21, 2019Binding Molecules For Bcma And Cd3BOEHRINGER INGELHEIM7
Sep 1, 2021Direct Compression Formulation And ProcessNOVARTIS7
Jul 3, 2019Pharmaceutical Compositions Comprising An S1P ModulatorNOVARTIS7
Mar 3, 2021Tofacitinib Oral Sustained Release Dosage FormsPFIZER6
Jun 26, 2024Pharmaceutical Formulations Comprising 4-{(1 R)-2-[(6-{2-[(2,6-Dichlorobenzyl)Oxy]Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2-(Hydroxymethyl)PhenolGLAXO GROUP6
Sep 2, 2020Process Of Modulating Man5 And/Or Afucosylation Content Of Glycoprotein CompositionDR REDDYS LABORATORIES5
Jul 27, 2022Use Of Dpp Iv InhibitorsBOEHRINGER INGELHEIM5